Methods, models, systems, and apparatus for identifying target sequences for Cas enzymes or CRISPR-Cas systems for target sequences and conveying results thereof

US10930367B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10930367-B2
Application numberUS-201514738483-A
CountryUS
Kind codeB2
Filing dateJun 12, 2015
Priority dateDec 12, 2012
Publication dateFeb 23, 2021
Grant dateFeb 23, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed are thermodynamic and multiplication methods concerning CRISPR-Cas systems, and apparatus therefor.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for selecting and producing an engineered CRISPR complex for targeting and/or cleavage of a candidate target nucleic acid sequence within a eukaryotic cell, comprising the steps of: (a) determining amount, location and nature of mismatch(es) of guide sequence of potential CRISPR complex(es) and the candidate target nucleic acid sequence, (b) determining contribution of each of the amount, location and nature of mismatch(es) to hybridization free energy of binding between the target nucleic acid sequence and the guide sequence of potential CRISPR complex(es) from a training data set, (c) based on the contribution analysis of step (b), predicting cleavage at the location(s) of the mismatch(es) of the target nucleic acid sequence by the potential CRISPR complex(es), (d) selecting the CRISPR complex from potential CRISPR complex(es) based on whether the prediction of step (c) indicates that it is more likely than not that cleavage will occur at location(s) of mismatch(es) by the CRISPR complex; (e) producing the selected CRISPR complex or nucleic acid molecule(s) encoding the selected CRISPR complex for targeting and/or cleavage of the candidate target nucleic acid sequence within the eukaryotic cell; and (f) delivering the selected CRISPR complex or nucleic acid molecule(s) encoding the selected CRISPR complex into the eukaryotic cell, wherein the selected CRISPR complex targets and/or cleaves the candidate target nucleic acid sequence within the eukaryotic cell. 2. The method of claim 1 wherein the candidate target sequence is a DNA sequence, and the mismatch(es) are of RNA of potential CRISPR complex(es) and the DNA. 3. The method of claim 1 , wherein step (b) is performed by determining known local free energies, ΔGij(k), between every guide RNA sequence i and target DNA nucleic acid sequence j at position k, calculating values of the effective free-energy Z ij using the relationship p ij ∝e −βZij ,where p ij is measured cutting frequency by guide RNA sequence i on target DNA nucleic acid sequence j in the training set and β is a positive constant of proportionality, determining the weights which are position-dependent weights α k by fitting the known value of ΔGij(k) and the calculated value of Z ij across each guide RNA/target DNA sequence pair in the training set in the sum across all N bases of the guide-sequence Z ij = ∑ k = 1 N ⁢ α k ⁢ Δ ⁢ G ij ⁡ ( k ) by writing the above equation in the matrix form {right arrow over (Z)}=G{right arrow over (α)} and wherein, step (c) is performed by estimating the effective free-energy Zest using the determined position dependent weights in the equation {right arrow over (Z est )}=G {right arrow over (α)} and determining estimated spacer-target cutting frequencies p est αe −βZest , to thereby predict cleavage. 4. The method of claim 2 wherein the distance, in bp, between the first and last base of the target sequence is 18. 5. The method of claim 1 wherein predicting cleavage comprises predicting whether cleavage is more likely than not to occur at location(s) of mismatch(es), and thereby predicting cleavage. 6. The method of claim 1 , further comprising normalizing the calculated values of the effective free energy of hybridization Z for each guide RNA/target DNA sequence pair in the training set. 7. The method of claim 1 , further comprising filtering out calculated value of the effective free energy of hybridization Z for each guide RNA/target DNA sequence pair in the training set which have a sequencing depth which is below a minimum sequencing depth. 8. The method of claim 1 , wherein the method is implemented by a computer system comprising: a. a memory unit configured to receive and/or store sequence information of the candidate target nucleic acid sequence; and b. one or more processors alone or in combination programmed to perform steps (a) to (d). 9. The method of claim 1 , wherein step (b) is performed by: defining a thermodynamic model having a set of weights linking effective free energy of hybridization Z to local free energies G; defining a training set of the guide sequence/target DNA sequence pairs; inputting known values of local free energies G for each guide sequence/target DNA sequence pair in the training set; calculating a value of effective free energy of hybridization Z for each guide sequence/target DNA sequence pair in the training set; determining the weights using a machine learning algorithm, and outputting the weights whereby the weights can be used to estimate the free energy of hybridization for any sequence. 10. The method of claim 1 wherein the guide sequence is comprised within a single guide RNA (sgRNA) or within a CRISPR-Cas system chimera RNA (chiRNA). 11. The method of claim 1 , wherein the selected CRISPR complex generates a cleavage within the candidate target nucleic acid sequence within the eukaryotic cell.

Assignees

Inventors

Classifications

  • G16B20/00Primary

    ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations · CPC title

  • G16B20/30Primary

    Detection of binding sites or motifs · CPC title

  • Preparation or screening gene libraries by chromosomal integration of polynucleotide sequences, HR-, site-specific-recombination, transposons, viral vectors · CPC title

  • Design, preparation, screening or analysis of libraries using computer algorithms · CPC title

  • involving clustered regularly interspaced short palindromic repeats [CRISPR] · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10930367B2 cover?
Disclosed are thermodynamic and multiplication methods concerning CRISPR-Cas systems, and apparatus therefor.
Who is the assignee on this patent?
Broad Inst Inc, Massachusetts Inst Technology, Harvard College
What technology area does this patent fall under?
Primary CPC classification G16B20/00. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Feb 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).